Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Myeloproliferative Disorders × cabozantinib × Clear all

Sponsor

Conditions

Prostatic Neoplasms 13 Carcinoma, Renal Cell 12 Neoplasm Metastasis 7 Neoplasms 6 Carcinoma, Hepatocellular 5 Thyroid Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Medullary 4 Breast Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Neuroendocrine Tumors 3 Thyroid Cancer, Papillary 2 Small Cell Lung Carcinoma 2 Recurrence 2 Pain 2 Multiple Myeloma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Glioma 2 Glioblastoma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Astrocytoma 2 Adenoma, Islet Cell 2 Adenocarcinoma, Follicular 2 Adenocarcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1

Interventions

fludarabine phosphate 36 Whole-Body Irradiation 29 Mycophenolic Acid 27 Cyclophosphamide 26 Peripheral Blood Stem Cell Transplantation 24 Tacrolimus 21 Busulfan 18 Antilymphocyte Serum 18 fludarabine 16 Cyclosporine 14 ruxolitinib 13 Melphalan 13 Cytarabine 11 Methotrexate 10 thymoglobulin 9 Etoposide 9 Sirolimus 8 Filgrastim 7 Cyclosporins 7 Rituximab 6 Granulocyte Colony-Stimulating Factor 6 Cord Blood Stem Cell Transplantation 6 Radiotherapy 5 Alemtuzumab 5 ponatinib 4 Flow Cytometry 4 Azacitidine 4 Stem Cell Transplantation 3 Methylprednisolone 3 Mesna 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡